Comprehensive care in gynecologic oncology: The importance of palliative care. Read more about Comprehensive care in gynecologic oncology: The importance of palliative care.
Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States. Read more about Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States.
Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions. Read more about Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Accuracy of colposcopy in HIV seropositive and seronegative women with abnormal Pap tests. Read more about Accuracy of colposcopy in HIV seropositive and seronegative women with abnormal Pap tests.
Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer. Read more about Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer.
MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer. Read more about MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer.
Impact of socioeconomic status and ethnic enclave on cervical cancer incidence among Hispanics and Asians in California. Read more about Impact of socioeconomic status and ethnic enclave on cervical cancer incidence among Hispanics and Asians in California.
Predictors of high symptom burden in gynecologic oncology outpatients: who should be referred to outpatient palliative care? Read more about Predictors of high symptom burden in gynecologic oncology outpatients: who should be referred to outpatient palliative care?
Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study. Read more about Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.
Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome. Read more about Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome.
